123). It is actually notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for loss of Gls in MYC-induced mouse liver tumours40. This means that GLS2 could confer resistance to GLS1-distinct inhibitors, including the allosteric inhibitor BPTES or CB-839, and this resistance may very well be https://glycerol-phenylbutyrate43210.jiliblog.com/86510268/5-simple-techniques-for-diphenyleneiodonium-chloride